Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation

MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro

(2016) Kun-Chun Chiang et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Coupling of neurogenesis and angiogenesis after ischemic stroke

(2015) Linhui Ruan et al.   BRAIN RESEARCH

Modulating the Vascular Response to Limb Ischemia: Angiogenic and Cell Therapies

(2015) J. P. Cooke et al.   CIRCULATION RESEARCH

Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease

(2015) Radosław Wieczór et al.   Journal of Zhejiang University-SCIENCE B

Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro

(2015) Tonglie Huang et al.   Drug Design Development and Therapy

Glycaemic control improves perfusion recovery and VEGFR2 protein expression in diabetic mice following experimental PAD

(2014) Ayotunde O. Dokun et al.   CARDIOVASCULAR RESEARCH

BPC 157 and Blood Vessels

(2014) Sven Seiwerth et al.   CURRENT PHARMACEUTICAL DESIGN

Stable Gastric Pentadecapeptide BPC 157-NO-system Relation

(2014) Predrag Sikiric et al.   CURRENT PHARMACEUTICAL DESIGN

Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts

(2014) Chung-Hsun Chang et al.   MOLECULES

Low Energy Shock Wave Therapy Induces Angiogenesis in Acute Hind-Limb Ischemia via VEGF Receptor 2 Phosphorylation

(2014) Johannes Holfeld et al.   PLoS One

Endosome-to-Plasma Membrane Recycling of VEGFR2 Receptor Tyrosine Kinase Regulates Endothelial Function and Blood Vessel Formation

(2014) Helen Jopling et al.   Cells

Upregulated autocrine vascular endothelial growth factor (VEGF)/VEGF receptor-2 loop prevents apoptosis in haemangioma-derived endothelial cells

(2013) Y. Ji et al.   BRITISH JOURNAL OF DERMATOLOGY

VEGFR2 trafficking: Speed doesn’t kill

(2013) Xi Zhang et al.   CELL CYCLE

Essential Role for Endocytosis in the Growth Factor-stimulated Activation of ERK1/2 in Endothelial Cells

(2013) Morgane Gourlaouen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Receptor Tyrosine Kinase-Mediated Angiogenesis

(2013) M. Jeltsch et al.   Cold Spring Harbor Perspectives in Biology

T-cadherin attenuates insulin-dependent signalling, eNOS activation, and angiogenesis in vascular endothelial cells

(2012) Maria Philippova et al.   CARDIOVASCULAR RESEARCH

Treatment of Mouse Limb Ischemia with an Integrative Hypoxia-Responsive Vector Expressing the Vascular Endothelial Growth Factor Gene

(2012) Eduardo Gallatti Yasumura et al.   PLoS One

Effects of Simulated Microgravity on Human Umbilical Vein Endothelial Cell Angiogenesis and Role of the PI3K-Akt-eNOS Signal Pathway

(2012) Fei Shi et al.   PLoS One

Effect of Hypoxia-Inducible Factor-1α Gene Therapy on Walking Performance in Patients With Intermittent Claudication

(2011) Mark A. Creager et al.   CIRCULATION

Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia

(2011) Jill Belch et al.   LANCET

Revised Roberts Cytoprotection and Adaptive Cytoprotection and Stable Gastric Pentadecapeptide BPC 157. Possible Significance and Implications for Novel Mediator

(2010) Predrag Sikiric et al.   CURRENT PHARMACEUTICAL DESIGN

Monitoring of the Biological Response to Murine Hindlimb Ischemia With 64 Cu-Labeled Vascular Endothelial Growth Factor-121 Positron Emission Tomography

(2008) Jürgen K. Willmann et al.   CIRCULATION